Catalyst Pharmaceuticals (CPRX) Other Accumulated Expenses (2011 - 2026)

Catalyst Pharmaceuticals (CPRX) has 11 years of Other Accumulated Expenses data on file, last reported at $745000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 66.52% year-over-year to $745000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $745000.0 (down 66.52% YoY) and the FY2025 annual result came in at $840000.0, up 101.44% from the prior year.
• Other Accumulated Expenses eased to $745000.0 in Q1 2026, from $840000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.2 million in Q1 2025 to a low of $372000.0 in Q2 2024.
• A 4-year average of $789111.1 and a median of $745000.0 in 2026 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses soared 101.44% — and 2026, when it slumped 66.52%.
• Tracing CPRX's Other Accumulated Expenses over 4 years: stood at $465000.0 in 2023, then dropped by 10.32% to $417000.0 in 2024, then soared by 101.44% to $840000.0 in 2025, then slipped by 11.31% to $745000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $745000.0 (Q1 2026), $840000.0 (Q4 2025), and $842000.0 (Q3 2025), per Business Quant data.